Aggregation System Improves Analysis of Sub-Visible Particles

Publication
Article
BioPharm InternationalBioPharm International-04-01-2014
Volume 27
Issue 4

Aggregation System Improves Analysis of Sub-Visible Particles

Shimadzu introduces the Aggregates Sizer Aggregation Analysis System, which provides real-time quantitative evaluation of 100 nm to 10 μm sub-visible particle (SVP) aggregates. By screening and identifying aggregation-prone proteins in early-stage drug development, manufacturers can save time and reduce costs.

The Aggregates Sizer is capable of identifying all ranges of SVP particles from invisible to visible, in a single measurement in micro-sample quantities as small as 0.4 mL. It also enables quantitative evaluation of the concentration of those aggregates.

In addition, the Aggregates Sizer can execute ongoing measurements in intervals as short as one second, allowing users to evaluate rates of change at intermediate stages during the manufacturing process. A batch cell (5 mL sample capacity) enables observation of aggregation processes as samples are mechanically stimulated. This helps prevent the formation of aggregates during drug manufacturing and improves testing without the need for additional equipment.

Shimadzu Scientific Instruments

Recent Videos
Lee Cronin, founder and CEO of Chemify
Jay Rajagopalan, senior director—Engineering & Product Management for Malema at PSG Biotech | Image Credit: BioPharm International
© 2024 MJH Life Sciences

All rights reserved.